KALARIS THERAPEUTICS, INC. (KLRS)

Every figure this model derived for KLRS, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2019-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 93,538,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 95,921,000 AssetsCurrent 2026-06-30
current liabilities 8,738,000 LiabilitiesCurrent 2026-06-30
equity 57,672,000 StockholdersEquity 2026-06-30
revenue 165,000 RevenueFromContractWithCustomerExcludingAssessedTax 2019-12-31
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up KLRS on one particular measure came for.

RatioValue
current ratio10.98
current ratio reported10.98
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about KLRS's figures. Written by the derivation as it ran, not added afterwards.